PAHUX | RSLFX | PAHUX / RSLFX | |
Total Expense Ratio | 1.06 | 0.70 | 151% |
Annual Report Gross Expense Ratio | 3.69 | 0.70 | 527% |
Fund Existence | 4 years | 23 years | - |
Gain YTD | -10.026 | 3.580 | -280% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.38M | 75.5B | 0% |
Annual Yield % from dividends | 0.00 | 0.88 | - |
Returns for 1 year | -2.95 | 5.15 | -57% |
Returns for 3 years | 25.41 | 31.09 | 82% |
Returns for 5 years | N/A | 24.35 | - |
Returns for 10 years | N/A | 44.08 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MDLOX | 20.00 | -0.16 | -0.79% |
BlackRock Global Allocation Inv A | |||
CGCIX | 13.43 | -0.11 | -0.81% |
Calamos Global Opportunities I | |||
EIHSX | 13.47 | -0.14 | -1.03% |
Eaton Vance Worldwide Health Sci I | |||
PVEJX | 15.14 | -0.18 | -1.17% |
Principal MidCap Value I J | |||
GFVAX | 15.25 | -0.20 | -1.29% |
Goldman Sachs Focused Value A |